These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 38563112)
1. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening. Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112 [TBL] [Abstract][Full Text] [Related]
2. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population]. Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341 [No Abstract] [Full Text] [Related]
3. Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana. Luckett R; Ramogola-Masire D; Gompers A; Moraka N; Moyo S; Sedabadi L; Tawe L; Kashamba T; Gaborone K; Mathoma A; Noubary F; Kula M; Grover S; Dreyer G; Botha MH; Makhema J; Shapiro R; Hacker MR Int J Gynaecol Obstet; 2024 May; 165(2):507-518. PubMed ID: 37950533 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China. Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679 [TBL] [Abstract][Full Text] [Related]
5. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy. Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036 [TBL] [Abstract][Full Text] [Related]
6. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group. Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059 [TBL] [Abstract][Full Text] [Related]
7. Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up. Effah K; Tekpor E; Wormenor CM; Essel NOM; Kemawor S; Sesenu E; Danyo S; Kitcher YT; Klutsey GB; Tay G; Tibu F; Abankroh KA; Atuguba BH; Akakpo PK Ecancermedicalscience; 2023; 17():1645. PubMed ID: 38414966 [TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
9. Screening of cervical neoplasia in HIV-infected women in India. Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study. Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P; PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376 [TBL] [Abstract][Full Text] [Related]
12. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics. Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985 [TBL] [Abstract][Full Text] [Related]
13. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243 [TBL] [Abstract][Full Text] [Related]
14. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. Leinonen MK; Nieminen P; Lönnberg S; Malila N; Hakama M; Pokhrel A; Laurila P; Tarkkanen J; Anttila A BMJ; 2012 Nov; 345():e7789. PubMed ID: 23197596 [TBL] [Abstract][Full Text] [Related]
15. Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda. Murenzi G; Dusingize JC; Rurangwa T; Sinayobye JD; Munyaneza A; Murangwa A; Zawadi T; Hebert T; Mugenzi P; Adedimeji A; Mutesa L; Anastos K; Castle PE BMJ Open; 2018 Aug; 8(8):e020432. PubMed ID: 30082342 [TBL] [Abstract][Full Text] [Related]
16. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana. Effah K; Tekpor E; Wormenor CM; Amuah JE; Essel NO; Atuguba BH; Klutsey GB; Sesenu E; Tay G; Tibu F; Kemawor S; Gedzah I; Morkli EAC; Danyo S; Akakpo PK PLOS Glob Public Health; 2023; 3(4):e0001830. PubMed ID: 37079498 [TBL] [Abstract][Full Text] [Related]
17. [A study of cervical cancer screening algorithms]. Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481 [TBL] [Abstract][Full Text] [Related]
18. Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana. Dei-Adomakoh Y; Effah K; Tekpor E; Crabbe S; Amuah JE; Wormenor CM; Tay G; Asare EV; Kemawor S; Danyo S; Morkli EAC; Tibu F; Essel NO; Akakpo PK Ecancermedicalscience; 2023; 17():1571. PubMed ID: 37533951 [TBL] [Abstract][Full Text] [Related]
19. Mobile colposcopy by trained nurses in a cervical cancer screening programme at Battor, Ghana. Effah K; Wormenor MC; Tekpor E; Amuah JE; Atuguba HB; Mensah ENO; Badzi ES; Danyo S; Agyiri D; Klutsey GB; Akakpo PK Ghana Med J; 2022 Sep; 56(3):141-151. PubMed ID: 37448995 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus test with cytology triage in organized screening for cervical cancer. Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]